Abstract:Purpose The purpose of this paper is to exploit the effect of equity financing constraints on the firm’s investment in research and development (R&D) by utilizing a quasi-experiment in China. Design/methodology/approach A difference-in-difference identification strategy is employed to test the treatment effect of the IPO suspension in China. For robustness testing, the authors incorporate cross-sectional variation in external financial dependence to identify the different influences an IPO suspension has on R&D investments for firms across multiple industries through the difference-in-difference-in-difference approach and the authors also adopt a matching approach to check the parallel trend assumption. Moreover, the authors introduce a placebo test to further verify the empirical results. Findings Through the empirical analysis, the authors find that the firms subjecting to the IPO suspension are more likely to reduce their investments in R&D than those not affected by the IPO suspension. Besides, the negative effect of equity financing constraints on R&D investments is concentrated on external financial dependent industries. The firms in industries with larger external financial dependence tend to decrease more in their R&D expenditures when they experience the equity financing constraints. Research limitations/implications This paper provides a new negative evidence on equity financing constraints on R&D investments link so that contributes to the debate about the effect of the financing constraints on R&D investments. Practical implications The study provides a meaningful suggestion for governments to diminish the frictions in the financial market and to improve enterprises’ public financing circumstances by finding that equity financing constraints have negative impacts on firms’ R&D investments. Originality/value There are some apprehensions around previous empirical studies investigating the impact of financing constraints on R&D investments as the existing literature is unable to provide an unambiguous method to exactly distinguish and measure the degree of financing constraints the firms confronting with. This paper solves this problem by first utilizing an IPO suspension in China as a quasi-experiment to examine the effect of equity financing constraints. Therefore, it gives insight to solve the problem of measuring financing constraints in future researches.

The distinct signaling effects of R&D subsidy and non-R&D subsidy on IPO performance of IT entrepreneurial firms in China

The Impact of Technology Identification Policy on Firm Innovation: Evidence from China

Initial Public Offering, Corporate Innovation and Total Factor Productivity: Evidence from China

The Signaling Effect of Entrepreneurship Subsidies on Initial Public Offering Investor Valuation: an Anticorruption Campaign As a Quasi‐natural Experiment

The Effect of Government Subsidies on Firm R&D Investment in China: From Perspectives of Ownership and Market Power

The long-run performance of initial public offerings and its determinants: the case of China

R&D subsidy, non-R&D subsidy and institutional investors' subscription for private placement of new shares: Evidence from China's securities market

Enterprises’ R&D Investment, Venture Capital Syndication and IPO Underpricing

Investigating the Impact of Regional Digital Finance Development on Short-run IPO Performance: Empirical Evidence from China

Indirect effects of direct subsidies: an examination of signaling effects

Uncertainty of Political Subsidy, Heterogeneous Beliefs, and IPO Anomalies

Sponsor Co-investment, inquiry divergence, and IPO pricing efficiency

IPO policy and IPO underpricing: Evidence from the registration-based IPO reform in China

Does internationalization encourage state-owned enterprises to utilize subsidies to innovate? Evidence from high-tech and automobile manufacturing industries of Chinese listed companies

Equity financing constraints and R&D investments: evidence from an IPO suspension in China

Institutional environment, firm ownership, and IPO first-day returns: Evidence from China

Funding Forms, Market Conditions, and Dynamic Effects of Government R&D Subsidies: Evidence from China

IPO pricing deregulation and corporate governance: Theory and evidence from Chinese public firms

Performance feedback and firms’ R&D frequency: a comparison between state-owned and private-owned enterprises in China

Tax incentive, R&D investment and firm innovation: Evidence from China

Can government subsidies improve innovation performance? Evidence from Chinese listed companies